
Edward Roberts Jr.
Examiner (ID: 15270)
| Most Active Art Unit | 2402 |
| Art Unit(s) | 3405, 3203, 1205, 2402, 2412 |
| Total Applications | 1571 |
| Issued Applications | 1483 |
| Pending Applications | 4 |
| Abandoned Applications | 84 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16569009
[patent_doc_number] => 20210008015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => HEPATOPROTECTENT PHENYLBUTYRATYRATE DRUG CONJUGATES, AND THEIR COMPOSITIONS PREPARATION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/509562
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16509562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/509562 | HEPATOPROTECTENT PHENYLBUTYRATYRATE DRUG CONJUGATES, AND THEIR COMPOSITIONS PREPARATION AND METHODS OF USE THEREOF | Jul 11, 2019 | Abandoned |
Array
(
[id] => 15347921
[patent_doc_number] => 20200011852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHODS FOR PREDICTING THE ANTICANCER THERAPEUTIC RESPONSE OF L-ASCORBIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/505864
[patent_app_country] => US
[patent_app_date] => 2019-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505864 | METHODS FOR PREDICTING THE ANTICANCER THERAPEUTIC RESPONSE OF L-ASCORBIC ACID | Jul 8, 2019 | Abandoned |
Array
(
[id] => 15589573
[patent_doc_number] => 20200071321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => METHODS AND USES OF COMPOUNDS FOR TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/502743
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502743
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502743 | METHODS AND USES OF COMPOUNDS FOR TREATING DISEASE | Jul 2, 2019 | Abandoned |
Array
(
[id] => 15020675
[patent_doc_number] => 20190321342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
[patent_app_type] => utility
[patent_app_number] => 16/451591
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451591 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | Jun 24, 2019 | Abandoned |
Array
(
[id] => 16969298
[patent_doc_number] => 11065244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Methods of use of tetrahydroberberine (THB)
[patent_app_type] => utility
[patent_app_number] => 16/445492
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12074
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445492 | Methods of use of tetrahydroberberine (THB) | Jun 18, 2019 | Issued |
Array
(
[id] => 16743206
[patent_doc_number] => 10968180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Piperidine derivatives as HDAC1/2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/433386
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25838
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433386 | Piperidine derivatives as HDAC1/2 inhibitors | Jun 5, 2019 | Issued |
Array
(
[id] => 16885276
[patent_doc_number] => 20210171471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => Benzimidazole Derivatives as Modulators of Retinoid-Related Orphan Receptor Gamma (RORy) and Pharmaceutical Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/052451
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052451 | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORg) and pharmaceutical uses thereof | May 2, 2019 | Issued |
Array
(
[id] => 15114411
[patent_doc_number] => 20190343838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/402538
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 186041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402538
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402538 | KRAS G12C inhibitors and methods of using the same | May 2, 2019 | Issued |
Array
(
[id] => 14743707
[patent_doc_number] => 20190255027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
[patent_app_type] => utility
[patent_app_number] => 16/400227
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400227 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | Apr 30, 2019 | Abandoned |
Array
(
[id] => 16748794
[patent_doc_number] => 20210100803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/048282
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048282 | Methods and compositions for treating cancer | Apr 16, 2019 | Issued |
Array
(
[id] => 17028488
[patent_doc_number] => 11090286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Methods of treating and preventing breast cancer with S-equol
[patent_app_type] => utility
[patent_app_number] => 16/384417
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 17
[patent_no_of_words] => 10691
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384417
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384417 | Methods of treating and preventing breast cancer with S-equol | Apr 14, 2019 | Issued |
Array
(
[id] => 17569882
[patent_doc_number] => 11318136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Identification of granins as the pathogenic factor of alzheimer's disease and compositions and methods for inhibiting granin aggregation and treating alzheimer's disease
[patent_app_type] => utility
[patent_app_number] => 16/382786
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 17686
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382786
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382786 | Identification of granins as the pathogenic factor of alzheimer's disease and compositions and methods for inhibiting granin aggregation and treating alzheimer's disease | Apr 11, 2019 | Issued |
Array
(
[id] => 17698282
[patent_doc_number] => 11372003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Biomarkers for graft-versus-host disease
[patent_app_type] => utility
[patent_app_number] => 16/381158
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23049
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381158 | Biomarkers for graft-versus-host disease | Apr 10, 2019 | Issued |
Array
(
[id] => 14649337
[patent_doc_number] => 20190231797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 16/377540
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377540 | TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS | Apr 7, 2019 | Abandoned |
Array
(
[id] => 18027251
[patent_doc_number] => 11510410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Pediculicidal composition
[patent_app_type] => utility
[patent_app_number] => 16/366573
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9025
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/366573 | Pediculicidal composition | Mar 26, 2019 | Issued |
Array
(
[id] => 16954853
[patent_doc_number] => 11058680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Combinations of opioid/TLR4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia
[patent_app_type] => utility
[patent_app_number] => 16/365101
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20158
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365101 | Combinations of opioid/TLR4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia | Mar 25, 2019 | Issued |
Array
(
[id] => 16657307
[patent_doc_number] => 20210053943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => JAK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/979455
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 480
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979455 | JAK inhibitors | Mar 17, 2019 | Issued |
Array
(
[id] => 14531575
[patent_doc_number] => 20190201408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => 6,7-DIALKOXY QUINAZOLINE DERIVATIVES AND METHODS OF TREATING DRUG RESISTANT AND OTHER TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/298944
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298944 | 6,7-DIALKOXY QUINAZOLINE DERIVATIVES AND METHODS OF TREATING DRUG RESISTANT AND OTHER TUMORS | Mar 10, 2019 | Abandoned |
Array
(
[id] => 16557582
[patent_doc_number] => 20210002730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALT CANCER
[patent_app_type] => utility
[patent_app_number] => 16/979364
[patent_app_country] => US
[patent_app_date] => 2019-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979364 | Compositions and methods for the diagnosis and treatment of ALT cancer | Mar 8, 2019 | Issued |
Array
(
[id] => 16655953
[patent_doc_number] => 20210052589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/977979
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977979 | COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE | Mar 6, 2019 | Pending |